Other Pharmacologic Adjuvant Therpy    Efficacy and Safety of Pyridoxal 5'-Phosphate (Mc-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The Mend-Cabg Ii Randomized Clinical Trial JAMA (2008) . Intracoronary Kai-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute St-Segment Elevation Myocardial Infarction Circulation (2008) 117;886-96 E. Bates, et al. High Dose Adenosine for Suboptimal Myocardial Reperfusion after Primary Pci: A Randomized Placebo-Controlled Pilot Study Catheter Cardiovasc Interv (2008) 71;283-9 M. G. Stoel, et al. A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous Mcc-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Evaluation of Mcc-135 for Left Ventricular Salvage in Acute Myocardial Infarction (Evolve) Am Heart J (2008) 155;113 e1-8 I. K. Jang, et al. High Dose Adenosine for Suboptimal Myocardial Reperfusion after Primary Pci: A Randomized Placebo-Controlled Pilot Study Catheter Cardiovasc Interv (2007) M. G. Stoel, et al. Adherence to Statin Therapy under Drug Cost Sharing in Patients with and without Acute Myocardial Infarction: A Population-Based Natural Experiment Circulation (2007) 115;2128-35 S. Schneeweiss, et al. Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early after Coronary Artery Bypass Surgery Circulation (2008) 117;24-31 J. L. Rouleau, et al. Statin Treatment in Children with Familial Hypercholesterolemia: The Younger, the Better Circulation (2007) 116;664-8 J. Rodenburg, et al. Treatment with Ezetimibe Plus Low-Dose Atorvastatin Compared with Higher-Dose Atorvastatin Alone: Is Sufficient Cholesterol-Lowering Enough to Inhibit Platelets? J Am Coll Cardiol (2007) 49;1035-42 M. Piorkowski, et al. Atorvastatin Pretreatment Improves Outcomes in Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention: Results of the Armyda-Acs Randomized Trial J Am Coll Cardiol (2007) 49;1272-8 G. Patti, et al. Pioglitazone Improves Myocardial Blood Flow and Glucose Utilization in Nondiabetic Patients with Combined Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Study J Am Coll Cardiol (2007) 50;2051-8 R. P. Naoumova, et al. Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size after Myocardial Ischemia and Reperfusion J Am Coll Cardiol (2007) 50;808-17 X. Liu, et al. Pretreatment with Intracoronary Enalaprilat Protects Human Myocardium During Percutaneous Coronary Angioplasty J Am Coll Cardiol (2007) 49;1607-10 M. A. Leesar, et al. Statin Use in Patients with Extremely Low Low-Density Lipoprotein Levels Is Associated with Improved Survival Circulation (2007) 116;613-8 N. J. Leeper, et al. Long-Term Safety of a Novel Antianginal Agent in Patients with Severe Chronic Stable Angina: The Ranolazine Open Label Experience (Role) J Am Coll Cardiol (2007) 49;1027-34 M. J. Koren, et al. Reduction of Neointimal Hyperplasia after Coronary Stenting by Pioglitazone in Nondiabetic Patients with Metabolic Syndrome Am Heart J (2007) 153;762 e1-7 T. Katayama, et al. A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous Mcc-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Evaluation of Mcc-135 for Left Ventricular Salvage in Acute Myocardial Infarction (Evolve) Am Heart J (2008) 155;113 e1-8 I. K. Jang, et al. Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients with Elevated High Sensitivity C-Reactive Protein: The Piostat Study J Am Coll Cardiol (2007) 49;290-7 M. Hanefeld, et al. Preliminary Experience with Intravenous P2y12 Platelet Receptor Inhibition as an Adjunct to Reduced-Dose Alteplase During Acute Myocardial Infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (Step-Ami) Angiographic Trial Am Heart J (2007) 154;702-9 A. B. Greenbaum, et al. Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery J Am Coll Cardiol (2007) 50;1649-56 H. H. Feringa, et al. The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients with Type 2 Diabetes and Previous Myocardial Infarction: Results from the Proactive (Proactive 05) Study J Am Coll Cardiol (2007) 49;1772-80 E. Erdmann, et al. Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients with Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (Sage) Circulation (2007) 115;700-7 P. Deedwania, et al. Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease Circulation (2007) P. S. Chan, et al. Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease Circulation (2007) 115;2398-409 P. S. Chan, et al. The Cardioprotective Effects of the Angiotensin-Converting Enzyme Inhibitor Perindopril in Patients with Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency: Insights from the Europa Trial J Am Coll Cardiol (2007) 50;2148-55 J. J. Brugts, et al. Pexelizumab for Acute St-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial JAMA (2007) 297;43-51 P. W. Armstrong, et al. Effect of Tilarginine Acetate in Patients with Acute Myocardial Infarction and Cardiogenic Shock: The Triumph Randomized Controlled Trial JAMA (2007) 297;1657-66 J. H. Alexander, et al. Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting Stent? Results of the Isar-Peace Randomized Trial J Am Coll Cardiol (2007) 49;1265-71 T. Adriaenssens, et al. Intensive Treatment of Hypertension Decreases the Risk of Hyperperfusion and Intracerebral Hemorrhage Following Carotid Artery Stenting Catheter Cardiovasc Interv (2007) 69;690-6 A. Abou-Chebl, et al.